Polio Working Group
The Bill & Melinda Gates Foundation (BMGF) is supporting computational modeling for decision making on polio eradication strategies. This working group has been created to join efforts on polio modeling and data access with the aim to advance the use of polio data for new models to maximize the impact and efficiency of polio eradication endgame strategies. READ MORE...
The April 2013 issue of the Risk Analysis Journal is a special issue on modeling poliovirus risks. Congratulations to the authors, several of whom are members of the Polio Modeling and Data Access Working Group: Cara Burns (CDC), Stephen Cochi (CDC), Radboud J. Duintjer Tebbens (Kid Risk), Dominika Kalkowska (Kid Risk), Sara Lowther (CDC), Rebecca Martin (CDC), Mark Pallansch (CDC), Roland Sutter (WHO), Kim Thompson (Kid Risk), and Steve Wassilak (CDC). Access to the eight papers is available by clicking on Resources / Publications above.
Scientific Declaration on Polio Eradication
On April 11, 2013, hundreds of scientists, doctors and technical experts from 80 countries launched the Scientific Declaration on Polio Eradication. Over 400 signatories joined together to stress the achievability of polio eradication and endorse the Eradication and Endgame Strategic Plan, a new strategy by the Global Polio Eradication Initiative (GPEI) to reach the end of polio by 2018.
To view more information, including a list of signatories and full declaration text, please visit the Emory Vaccine Center website: http://vaccines.emory.edu/poliodeclaration/
2013 Meeting of the Polio Modeling Working Group
The Centers for Disease Control and Prevention hosted a meeting of the Polio Modeling working group in Atlanta on January 29-30, 2013. The consortium was represented by participants from the Bill & Melinda Gates Foundation, Centers for Disease Control and Prevention, Emory University, Global Good, Imperial College London, Kid Risk, London School of Hygiene and Tropical Medicine, Rotary, Task Force for Global Health, UNICEF, University of Pittsburgh and World Health Organization.
Over the course of this two-day meeting, dynamic discussions took place on the main topics of: (Day 1) “Interruption of WPV transmission by 2014: Assess options to accelerate interruption of WPV transmission in specific remaining endemic reservoirs” ; and (Day 2) “Mitigation and management of cVDPV2 risks: Approaches to optimally withdraw OPV2 and introduce IPV.”
Slides from all presentations, final meeting minutes, and a revised proposed timeline, deliverables and priority questions for modeling studies document are available on this website under “Repository / Meetings.” These documents are password protected and login is required for access.